Universal Biosensors Inc
Company Profile
Business description
Universal Biosensors Inc is a biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food, and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride, and Xprecia Prime, which are medical devices; Sentia non-medical wine testing products, and Petrackr, which is a blood glucose test used in cats and dogs. It has one reportable segment: a specialist biosensors company. Geographically, the company generates the majority of its revenue from Australia and rest from Americas, Europe and other markets.
Contact
1 Corporate Avenue
RowvilleVIC3178
AUST: +61 392139000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
76
Stocks News & Analysis
stocks
Australia’s largest gold miner downgraded on a falling gold price
stocks
Cheap ASX share pays a heavy price for NRL rights
stocks
The World Cup stock you’ve never heard of
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,003.00 | 6.60 | 0.07% |
| CAC 40 | 8,333.70 | 5.26 | -0.06% |
| DAX 40 | 25,074.74 | 7.65 | 0.03% |
| Dow JONES (US) | 52,637.01 | 149.60 | 0.29% |
| FTSE 100 | 10,471.98 | 25.31 | -0.24% |
| HKSE | 24,213.72 | 38.60 | 0.16% |
| NASDAQ | 26,281.61 | 74.72 | 0.29% |
| Nikkei 225 | 67,242.73 | 1,315.00 | -1.92% |
| NZX 50 Index | 13,723.20 | 62.47 | -0.45% |
| S&P 500 | 7,575.39 | 31.75 | 0.42% |
| S&P/ASX 200 | 8,808.50 | 11.70 | 0.13% |
| SSE Composite Index | 3,913.79 | 82.37 | -2.06% |